Diagnostics

Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced that researchers...

Executives From NVIDIA, Mattel, Know Labs, Along With NBC, to Discuss New AI Trends at Edge Impulse’s Annual Imagine Conference

Attendees will include executives and professionals from Fortune 500 and leading technology companies in entertainment, healthcare, manufacturing and moreSAN JOSE,...

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023...

error: Content is protected !!